ATE409228T1 - Ausgeschiedene und transmembranpolypeptide und dafür kodierende nukleinsäure - Google Patents

Ausgeschiedene und transmembranpolypeptide und dafür kodierende nukleinsäure

Info

Publication number
ATE409228T1
ATE409228T1 AT05014619T AT05014619T ATE409228T1 AT E409228 T1 ATE409228 T1 AT E409228T1 AT 05014619 T AT05014619 T AT 05014619T AT 05014619 T AT05014619 T AT 05014619T AT E409228 T1 ATE409228 T1 AT E409228T1
Authority
AT
Austria
Prior art keywords
polypeptides
nucleic acid
secreted
present
acid coding
Prior art date
Application number
AT05014619T
Other languages
English (en)
Inventor
Luc Desnoyers
Dan L Eaton
Audrey Goddard
Paul J Godowski
Austin L Gurney
James Pan
Timothy A Stewart
Colin K Watanabe
William I Wood
Zemin Zhang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE409228T1 publication Critical patent/ATE409228T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
AT05014619T 1999-03-23 2000-03-01 Ausgeschiedene und transmembranpolypeptide und dafür kodierende nukleinsäure ATE409228T1 (de)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US12577499P 1999-03-23 1999-03-23
US12577899P 1999-03-23 1999-03-23
US12582699P 1999-03-24 1999-03-24
US12703599P 1999-03-31 1999-03-31
US12770699P 1999-04-05 1999-04-05
US13035999P 1999-04-21 1999-04-21
US13127099P 1999-04-27 1999-04-27
US13127299P 1999-04-27 1999-04-27
US13129199P 1999-04-27 1999-04-27
US13237999P 1999-05-04 1999-05-04
US13237199P 1999-05-04 1999-05-04
US13238399P 1999-05-04 1999-05-04
US13575099P 1999-05-25 1999-05-25
US13816699P 1999-06-08 1999-06-08
US14479199P 1999-07-20 1999-07-20
US14697099P 1999-08-03 1999-08-03
US17026299P 1999-12-09 1999-12-09

Publications (1)

Publication Number Publication Date
ATE409228T1 true ATE409228T1 (de) 2008-10-15

Family

ID=27586019

Family Applications (4)

Application Number Title Priority Date Filing Date
AT05011885T ATE417063T1 (de) 1999-03-23 2000-03-01 Sekretierte transmembranproteine und dafür kodierende nukleinsäuren
AT06005614T ATE449108T1 (de) 1999-03-23 2000-03-01 Ausgeschiedene und transmembrane polypeptide und dafür kodierende nukleinsäure
AT05014619T ATE409228T1 (de) 1999-03-23 2000-03-01 Ausgeschiedene und transmembranpolypeptide und dafür kodierende nukleinsäure
AT00917717T ATE329023T1 (de) 1999-03-23 2000-03-01 Ausgeschiedene und transmembran-polypeptide und dafür kodierende nukleinsäure

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT05011885T ATE417063T1 (de) 1999-03-23 2000-03-01 Sekretierte transmembranproteine und dafür kodierende nukleinsäuren
AT06005614T ATE449108T1 (de) 1999-03-23 2000-03-01 Ausgeschiedene und transmembrane polypeptide und dafür kodierende nukleinsäure

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT00917717T ATE329023T1 (de) 1999-03-23 2000-03-01 Ausgeschiedene und transmembran-polypeptide und dafür kodierende nukleinsäure

Country Status (11)

Country Link
EP (4) EP1169442B1 (de)
JP (8) JP4174183B2 (de)
KR (1) KR100504305B1 (de)
AT (4) ATE417063T1 (de)
AU (1) AU764092B2 (de)
CA (1) CA2361221A1 (de)
DK (3) DK1609863T3 (de)
ES (3) ES2269125T3 (de)
NZ (3) NZ536320A (de)
PT (3) PT1169442E (de)
WO (1) WO2000056889A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525174B1 (en) 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
US20030036114A1 (en) 1998-05-15 2003-02-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
IL143593A0 (en) * 1998-12-23 2002-04-21 Genentech Inc Il-1 related polypeptides
AU774436B2 (en) 1999-08-12 2004-06-24 Agensys, Inc. C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
US7842458B2 (en) 1999-08-12 2010-11-30 Agensys, Inc. Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer
EP1255837A2 (de) * 2000-02-08 2002-11-13 Amgen Inc. Il-17 ähnliche moleküle und ihre verwendungen
AU2001232305A1 (en) 2000-02-15 2001-08-27 Chugai Seiyaku Kabushiki Kaisha Novel protein having signal sequence
EP1259539A1 (de) * 2000-02-24 2002-11-27 Oxford GlycoSciences (UK) Limited Diagnose und behandlung von bipolarer affektiver störung
EP1275717A4 (de) * 2000-03-29 2004-10-06 Kyowa Hakko Kogyo Kk Mit proliferativer glomerularer nephritis assoziiertes gen
AU2002226033A1 (en) 2000-12-07 2002-06-18 Zymogenetics Inc. Adipocyte complement related protein zacrp3x2
JP4344519B2 (ja) * 2000-12-28 2009-10-14 旭化成ファーマ株式会社 ＮＦ−κＢ活性化遺伝子
WO2003000729A2 (en) * 2001-06-20 2003-01-03 Genentech, Inc. Secreted polypeptide and their use in the treatment of bone disorders
EP1513875A2 (de) * 2002-05-10 2005-03-16 Serono Genetics Institute S.A. Krib polynukleotide und polypeptide sowie deren verwendung zur behandlung von stoffwechselkrankheiten
US20070009515A1 (en) * 2002-05-31 2007-01-11 Hidetoshi Inoko Inflammatory skin disease-related slurp-2 gene and utilization thereof
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1790664A1 (de) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
ES2625259T3 (es) 2006-08-29 2017-07-19 Oxford Biotherapeutics Ltd Identificación de proteína asociada con carcinoma hepatocelular, glioblastoma y cáncer de pulmón
ES2639026T3 (es) 2009-03-05 2017-10-25 Oxford Biotherapeutics Ltd. Anticuerpos totalmente humanos específicos para CADM1
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
KR101695792B1 (ko) * 2014-09-04 2017-01-12 디오셀 주식회사 신규 세포막 투과 펩티드 및 생리활성 물질 전달체로서의 그의 용도

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US5206161A (en) 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
EP0791009A4 (de) * 1994-11-07 2003-03-05 Merck & Co Inc Modifizierter neuropeptid-y-rezeptor
WO1997025427A1 (en) * 1996-01-12 1997-07-17 Genetics Institute, Inc. Beta-chemokine, h1305 (mcp-2)
JP2001512013A (ja) 1997-08-01 2001-08-21 ジェンセット 前立腺に発現される分泌タンパク質の５’ｅｓｔ
ATE361933T1 (de) * 1997-08-01 2007-06-15 Serono Genetics Inst Sa 5' ests für sekretierte proteine aus gehirngeweben
AU758004B2 (en) 1997-12-17 2003-03-13 Genset S.A. Extended cDNAs for secreted proteins
EP1068312A2 (de) 1998-04-09 2001-01-17 Genset Humane 5' est's und kodierte proteine
AU758074B2 (en) * 1998-04-29 2003-03-13 Genesis Research And Development Corporation Limited Polynucleotides isolated from skin cells and methods for their use
JP2002532083A (ja) 1998-12-17 2002-10-02 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ４７個のヒト分泌タンパク質
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
CA2383592A1 (en) * 1999-03-31 2000-10-05 Curagen Corporation 2384891 acids including open reading frames encoding polypeptides; orfx
WO2000078802A2 (en) 1999-06-23 2000-12-28 Curagen Corporation Secreted polypeptides and corresponding polynucleotides
EP1074617A3 (de) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
AU774436B2 (en) * 1999-08-12 2004-06-24 Agensys, Inc. C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
AU6321400A (en) * 1999-08-17 2001-03-13 Protegene Inc. Human proteins having hydrophobic domains and dnas encoding these proteins
US6635742B1 (en) 2000-01-25 2003-10-21 Nuvelo, Inc. Antibodies specific for semaphorin-like polypeptides

Also Published As

Publication number Publication date
WO2000056889A3 (en) 2001-04-26
EP1609863B1 (de) 2008-09-24
JP4402034B2 (ja) 2010-01-20
ES2319202T3 (es) 2009-05-05
PT1616878E (pt) 2009-03-18
ES2269125T3 (es) 2007-04-01
PT1169442E (pt) 2006-10-31
NZ527293A (en) 2005-01-28
JP4398937B2 (ja) 2010-01-13
AU3864800A (en) 2000-10-09
JP2006101880A (ja) 2006-04-20
EP1609863A2 (de) 2005-12-28
PT1609863E (pt) 2009-01-02
ATE417063T1 (de) 2008-12-15
CA2361221A1 (en) 2000-09-28
JP2006115847A (ja) 2006-05-11
JP4392759B2 (ja) 2010-01-06
JP2010075189A (ja) 2010-04-08
EP1688430A2 (de) 2006-08-09
DK1609863T3 (da) 2008-12-15
ATE449108T1 (de) 2009-12-15
EP1616878B1 (de) 2008-12-10
DK1616878T3 (da) 2009-03-30
KR20010112927A (ko) 2001-12-22
EP1169442A2 (de) 2002-01-09
JP2003527074A (ja) 2003-09-16
EP1616878A1 (de) 2006-01-18
AU764092B2 (en) 2003-08-07
EP1169442B1 (de) 2006-06-07
JP2006158392A (ja) 2006-06-22
NZ536320A (en) 2006-04-28
WO2000056889A2 (en) 2000-09-28
JP2006136325A (ja) 2006-06-01
EP1688430A3 (de) 2006-11-02
DK1169442T3 (da) 2006-10-16
JP2006115848A (ja) 2006-05-11
EP1688430B1 (de) 2009-11-18
JP4174183B2 (ja) 2008-10-29
NZ527292A (en) 2005-03-24
KR100504305B1 (ko) 2005-07-28
JP4392760B2 (ja) 2010-01-06
JP2006101881A (ja) 2006-04-20
EP1609863A3 (de) 2006-04-12
ES2314521T3 (es) 2009-03-16
ATE329023T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
ATE478145T1 (de) Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren
ATE447583T1 (de) Polypeptide und dafür kodierende nukleinsäure
ATE449108T1 (de) Ausgeschiedene und transmembrane polypeptide und dafür kodierende nukleinsäure
ATE310810T1 (de) Polypeptid und dafür kodierendes nukeinsäure
DE69932266D1 (de) Sekretiertes und transmembranes Polypeptid und dafür kodierende Nukleinsäure
KR100515858B1 (en) PRO617 Polypeptides
DE60043242D1 (de) Ausgeschiedene und transmembrane Polypeptide und dafür kodierende Nukleinsäure
ATE396201T1 (de) Ausgeschiedene und transmembranpolypeptide und dafür kodierende nukleinsäure
ATE363537T1 (de) Ausgeschiedene und transmembranpolypeptide und dafür kodierende nukleinsäure
ATE300553T1 (de) Sekretiertes polypeptide und dafür kodierende nukleinsäuren
ATE321136T1 (de) Sekretierte und transmembrane polypeptide und dafür kodierende nukleinsäuren
ATE380864T1 (de) Menschliches prostasin-ähnliches protein und dafür kodierende nukleinsäure
KR100515856B1 (en) PRO618 Polypeptides
ATE282047T1 (de) Polypeptide und dafür kodierende nukleinsäure
DE69939227D1 (de) Menschliches A33-Antigen-ähnliches Protein und dafür kodierende Nukleinsäure
ATE291085T1 (de) Polypeptide und dafür kodierende nukleinsäure
ATE290018T1 (de) Polypeptid und dafür kodieredes nukleinsäure
DE69824455D1 (de) PRO241 Polypeptide und dafür kodierende Nukleinsäuren
ATE404585T1 (de) Menschliches synaptogyrin-ähnliches protein und dafür kodierende nukleinsäure
ATE405590T1 (de) Menschliches hcar-ähnliches protein und dafür kodierende nukleinsäure

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1609863

Country of ref document: EP

REN Ceased due to non-payment of the annual fee